SI-BONE (SIBN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on SI-BONE (SIBN) is Neutral.

The composite score behind that read is +0.06, weighing +0.12 of bullish evidence against -0.27 bearish.

SI-BONE last closed at $19.37, +2.70% on the session.

Against the IVW growth benchmark the position is +1.90% over the forecast window.

The read is built from 15 underlying insights — 7 bullish and 8 bearish.

Agreement across those insights is 53%.

14 graded predictions for SIBN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks SI-BONE in the 33rd percentile on return on equity, where 100 is best.

SI-BONE is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $845.29M.

StockMap tracks SI-BONE as the 66th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite SI-BONE ranks 30th of 140 in the group, against a group median of -0.03.